2008 annual financial data

Corcept Therapeutics 2008 Net margin

Corcept Therapeutics 2008 net margin with verified reported values.

Direct answer

Net margin was -9,598.56%.

Operating income was -19,689,000 USD and net income was -20,061,000 USD.
Operating cash flow was -18,362,000 USD.

Get free Corcept Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
209,000 USD
Operating income
-19,689,000 USD
Net income
-20,061,000 USD
Operating cash flow
-18,362,000 USD